Selzentry Tablet, Film Coated
Product Images NDC 49702-224

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Selzentry (NDC 49702-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Selzentry Spl Graphic 01)

Chemical structure diagram of maraviroc, the active ingredient in SELZENTRY, showing its complex molecular arrangement with fluorine atoms and multiple ring structures.*

FDA Label Image

Carton Contents (Selzentry Spl Graphic 02)

An instructional illustration showing a bottle alongside two oral syringes (3-mL small and 10-mL large) and a press-in bottle adapter with labeled parts: barrel and plunger of the syringes. The items are arranged for clear identification of each component.*

FDA Label Image

Figure A (Selzentry Spl Graphic 03)

An instructional illustration showing a person using both hands to open a bottle by pressing down on the cap and turning it counterclockwise, indicating a child-resistant safety cap removal method.*

FDA Label Image

Figure B (Selzentry Spl Graphic 04)

An instructional illustration showing how to open a child-resistant bottle cap. The left image depicts a hand pressing down on the cap, and the right image shows a hand turning the cap while pressing down, indicated by a downward arrow. The bottle is cylindrical and unlabeled.*

FDA Label Image

Figure C (Selzentry Spl Graphic 05)

An instructional illustration showing two oral syringes: a 3-mL small oral syringe labeled for doses of 2.5 mL or less, and a 10-mL large oral syringe labeled for doses more than 2.5 mL, with volume markings for precise measurement.*

FDA Label Image

Figure D (Selzentry Spl Graphic 06)

Illustration showing a hand holding a syringe with an arrow pointing upward near the needle tip, possibly indicating the expulsion of air or preparation step before injection.*

FDA Label Image

Figure E (Selzentry Spl Graphic 07)

Illustration showing a hand using a dropper or syringe to withdraw liquid from a bottle, with an arrow indicating the downward motion into the bottle. This instructional image is likely related to drug preparation or administration steps.*

FDA Label Image

Figure F (Selzentry Spl Graphic 08)

An instructional illustration showing a hand holding a bottle and drawing liquid into a syringe with the other hand. The image includes a downward arrow indicating the direction to pull the syringe plunger to draw the liquid.*

FDA Label Image

Figure G (Selzentry Spl Graphic 09)

An instructional illustration showing two hands, one holding a bottle and the other holding a syringe vertically above the bottle with an upward arrow, indicating the syringe should be pulled upward from the bottle.*

FDA Label Image

Figure H (Selzentry Spl Graphic 10)

An instructional diagram of a syringe showing a measurement line with a label indicating 'Measure to the top of the plunger.' The image demonstrates how to properly measure liquid using the syringe.*

FDA Label Image

Figure I (Selzentry Spl Graphic 11)

An instructional illustration showing a person administering oral medication to a baby using a syringe. The syringe is placed near the baby's mouth, with an arrow indicating the direction of administration.*

FDA Label Image

Figure J (Selzentry Spl Graphic 12)

Illustration depicting a hand holding a syringe and administering oral medication into the mouth of a young child, with an arrow indicating forward motion. The image shows a method of oral drug delivery, likely for liquid formulation.*

FDA Label Image

Figure K (Selzentry Spl Graphic 13)

An instructional diagram illustrating how to open a child-resistant bottle cap by pressing down and turning the cap counterclockwise while holding the bottle firmly.*

FDA Label Image

Figure L (Selzentry Spl Graphic 14)

An instructional illustration showing two hands pulling apart a syringe by separating the plunger from the barrel, indicated by arrows pointing outward in opposite directions.*

FDA Label Image

Figure M (Selzentry Spl Graphic 15)

An illustration showing two hands preparing or handling syringes. One hand appears to hold a syringe plunger while the other supports the barrel of another syringe, suggesting a medical or procedural context related to injection preparation. No text or labels are visible.*

FDA Label Image

Selzentry 25 mg 120 Count Label (Selzentry Spl Graphic 16)

An instructional illustration showing two hands demonstrating the use of a small container or vial. One hand holds the container while the other hand presses down on the top, indicated by a downward arrow, suggesting an action such as pressing or inserting a part into the container.*

FDA Label Image

Selzentry 75 mg 120 Count Label (Selzentry Spl Graphic 17)

Label for Selzentry (maraviroc) tablets 25 mg, oral dosage form, containing 120 tablets. The label includes storage instructions, dispensing guidance, and is manufactured for ViiV Healthcare Company. The NDC number 49702-233-08 is displayed alongside a barcode and expiration, lot, and serial number fields.*

FDA Label Image

Selzentry 150 mg 60 Count Label (Selzentry Spl Graphic 18)

The label is for Selzentry (maraviroc) tablets, 75 mg strength. It is a prescription oral tablet product by ViiV Healthcare Company. The label indicates a bottle containing 120 tablets with storage instructions and warnings about the safety seal and dispensing in tight containers. It also includes NDC, barcode, and manufacturing information.*

FDA Label Image

Selzentry 300 mg 60 Count Label (Selzentry Spl Graphic 19)

Selzentry 150 mg tablets label for oral use, containing maraviroc. The film-coated tablet package contains 60 tablets and is labeled as prescription-only. The product is manufactured for ViiV Healthcare Company, made in Belgium, with storage instructions between 20°C to 25°C. The label includes a barcode, NDC 49702-223-18, and warnings about the safety seal and dispensing.*

FDA Label Image

Selzentry Oral Solution 20 mg Per mL 230 mL Carton (Selzentry Spl Graphic 20)

Label for Selzentry (maraviroc) tablets, 300 mg strength, oral film-coated tablets. The label indicates a 60-tablet package, Rx only, manufactured by ViiV Healthcare Company. It includes storage instructions and a warning about the safety seal.*

FDA Label Image

Selzentry Spl Graphic 21

Label for Selzentry (maraviroc) oral solution 20 mg/mL in a 230 mL bottle. The label includes dispensing instructions, a list of contents such as an oral solution bottle, dosing syringe, bottle adapter, prescribing information, medication guide, and instructions for use. It states 'Rx only.'*

FDA Label Image

Selzentry Spl Graphic 22

Selzentry (maraviroc) oral solution 20 mg/mL 230 mL bottle label showing contents including oral dosing syringes, a press-in bottle adapter, prescribing information, medication guide, and usage instructions. The label indicates it is a prescription-only medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.